Kintara Therapeutics, Inc. (KTRA)
USD 0.22
(-6.31%)
USD 0.22
(-6.31%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.17 Million | -11.86 Million | -20.39 Million | -18.86 Million | -7.92 Million | -6.32 Million |
| Net Income | -8.32 Million | -14.64 Million | -22.66 Million | -38.29 Million | -9.12 Million | -8.04 Million |
| Depreciation & Amortization | 55 Thousand | 60 Thousand | 60 Thousand | 32 Thousand | 9953.00 | 16.34 Thousand |
| Deferred income taxes | - | 200 Thousand | - | 16.66 Million | 193.48 Thousand | -409.78 Thousand |
| Stock-based compensation | 607 Thousand | 1.49 Million | 2.24 Million | 5.27 Million | 495 Thousand | 952.17 Thousand |
| Change in working capital | 291 Thousand | -2.19 Million | -55 Thousand | -2.65 Million | 486.7 Thousand | 1.13 Million |
| Other non-cash items | 191 Thousand | 3.22 Million | 16 Thousand | 118 Thousand | 13.39 Thousand | 27.27 Thousand |
| Investing Cash Flow | -20 Thousand | -232 Thousand | 964 Thousand | 964 Thousand | - | - |
| Investments in PPE | -20 Thousand | -232 Thousand | - | -8000.00 | - | - |
| Acquisitions | - | - | - | 969 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -20 Thousand | - | 964 Thousand | 3000.00 | - | - |
| Financing Cash Flow | 10.57 Million | 1.85 Million | 21.63 Million | 26.04 Million | 6601.00 | 4.07 Million |
| Debt repayment | - | - | - | -500 Thousand | - | - |
| Dividends payments | -6000.00 | -8000.00 | -8000.00 | -8000.00 | -8000.00 | -8356.00 |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 10.57 Million | 1.9 Million | 21.56 Million | 21.59 Million | 6.63 Million | 3.36 Million |
| Other Financing Activities | 10.57 Million | -43 Thousand | 74 Thousand | 4.95 Million | 6609.00 | 720.16 Thousand |
| Accounts receivables | - | - | - | - | 16.78 Thousand | 13.33 Thousand |
| Accounts payables | -577 Thousand | -442 Thousand | 1 Million | -67 Thousand | 206.59 Thousand | 202 Thousand |
| Inventory | - | - | - | - | -16.78 Thousand | -13.33 Thousand |
| Other working capital | 868 Thousand | -1.75 Million | -1.06 Million | -2.58 Million | 280.11 Thousand | 932.79 Thousand |
| Cash at beginning of period | 1.53 Million | 11.78 Million | 10.53 Million | 2.39 Million | 3.71 Million | 5.97 Million |
| Cash at end of period | 4.9 Million | 1.53 Million | 11.78 Million | 10.53 Million | 2.39 Million | 3.71 Million |
| Capital Expenditure | -20 Thousand | -232 Thousand | - | -8000.00 | - | - |
| Effect of forex changes on cash | - | - | -964 Thousand | - | - | - |
| Net cash flow / Change in cash | 3.37 Million | -10.24 Million | 1.24 Million | 8.14 Million | -1.32 Million | -2.25 Million |
| Free Cash Flow | -7.19 Million | -12.09 Million | -20.39 Million | -18.86 Million | -7.92 Million | -6.32 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.32 Million | -2.01 Million | -1.02 Million | -2.96 Million | -14.64 Million | -3.33 Million |
| Depreciation & Amortization | 17 Thousand | 8000.00 | 15 Thousand | 15 Thousand | 60 Thousand | 15 Thousand |
| Deferred income taxes | 1.47 Million | - | -1.47 Million | - | 200 Thousand | 200 Thousand |
| Stock-based compensation | 126 Thousand | 156 Thousand | 165 Thousand | 160 Thousand | 1.49 Million | 246 Thousand |
| Change in working capital | 701 Thousand | -508 Thousand | -1.32 Million | 1.42 Million | -2.19 Million | 453 Thousand |
| Other non-cash items | 38 Thousand | 706 Thousand | 1.52 Million | 48 Thousand | 3.22 Million | 913 Thousand |
| Investing Cash Flow | 20 Thousand | - | -20 Thousand | - | -232 Thousand | - |
| Investments in PPE | 20 Thousand | - | -20 Thousand | - | -232 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | 7.99 Million | 2.57 Million | -2000.00 | 1.85 Million | -2000.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | -2000.00 | -2000.00 | -2000.00 | -8000.00 | -2000.00 |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -10.57 Million | 7.99 Million | 2.58 Million | - | 1.9 Million | 43 Thousand |
| Other Financing Activities | 10.56 Million | 7995.00 | 2581.00 | - | -43 Thousand | -43 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 964 Thousand | -479 Thousand | -1.27 Million | 214 Thousand | -442 Thousand | 174 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -263 Thousand | -29 Thousand | -48 Thousand | -214 Thousand | -1.75 Million | 279 Thousand |
| Cash at beginning of period | 6.35 Million | 658 Thousand | 216 Thousand | 1.53 Million | 11.78 Million | 3.04 Million |
| Cash at end of period | 4.9 Million | 6.35 Million | 658 Thousand | 216 Thousand | 1.53 Million | 1.53 Million |
| Capital Expenditure | 20 Thousand | - | -20 Thousand | - | -232 Thousand | - |
| Effect of forex changes on cash | 465 Thousand | - | -465 Thousand | - | - | - |
| Net cash flow / Change in cash | -1.44 Million | 5.69 Million | 442 Thousand | -1.31 Million | -10.24 Million | -1.51 Million |
| Free Cash Flow | -1.42 Million | -2.3 Million | -2.13 Million | -1.31 Million | -12.09 Million | -1.5 Million |
0I8W
BIOE
ANI
JETFREIGHT
009180
ARET